Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BMC 128

Next Previous
Drug Profile

BMC 128

Alternative Names: BMC-128; LS-LBP-002

Latest Information Update: 15 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biomica
  • Class Antineoplastics; Bacteria; Immunotherapies
  • Mechanism of Action Bacteria replacements; Microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Renal cell carcinoma
  • Phase I Malignant melanoma; Non-small cell lung cancer

Most Recent Events

  • 01 Jul 2026 Phase-II clinical trials in Renal cell carcinoma (PO) (Lishan Biotech pipeline, July 2026)
  • 02 Jun 2026 Efficacy, adverse event and pharmacodynamic data from data from a phase I trial in Solid tumours released by Evogene
  • 02 Jun 2026 Biomica completes a phase I trial in Malignant melanoma, Non-small cell lung cancer and Renal cell carcinoma (Combination therapy, Inoperable/Unresectable, Late-stage disease, Metastatic disease, Second-line therapy or greater) in Israel (PO) (NCT05354102)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top